Stocks and Investing
Stocks and Investing
Wed, April 20, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Erin Wright Maintained (XRAY) at Buy with Decreased Target to $52 on, Apr 20th, 2022
Erin Wright of Morgan Stanley, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy with Decreased Target from $62 to $52 on, Apr 20th, 2022.
Erin has made no other calls on XRAY in the last 4 months.
There are 5 other peers that have a rating on XRAY. Out of the 5 peers that are also analyzing XRAY, 3 agree with Erin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Johnson of "Baird" Downgraded from Buy to Hold and Held Target at $48 on, Tuesday, April 19th, 2022
- John Kreger of "William Blair" Downgraded from Buy to Hold on, Tuesday, April 19th, 2022
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $59 on, Tuesday, March 1st, 2022
These are the ratings of the 2 analyists that currently disagree with Erin
- Matt Miksic of "Credit Suisse" Maintained at Buy with Decreased Target to $67 on, Tuesday, March 1st, 2022
- Jeff Johnson of "Baird" Maintained at Buy with Decreased Target to $67 on, Friday, February 18th, 2022
Contributing Sources